Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature

Identifieur interne : 003A53 ( Pmc/Checkpoint ); précédent : 003A52; suivant : 003A54

Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature

Auteurs : Shona Wynd [Royaume-Uni, Australie] ; Wayne D. Melrose [Australie] ; David N. Durrheim [Australie] ; Jaime Carron [Canada] ; Margaret Gyapong [Ghana]

Source :

RBID : PMC:2636343

Abstract

Abstract

Lymphatic filariasis (LF) is endemic in approximately 80 tropical and subtropical countries. About 120 million people are infected with the parasite and a billion are estimated to be at risk of infection. The main focus of the LF elimination programme to date has been to interrupt transmission by means of annual community-wide treatment campaigns with diethylcarbamazine and albendazole, or albendazole and ivermectin, for a period of four to six years. Although substantial progress has been recorded wherever the strategy has been successfully implemented, initial gains have been accompanied by a realization that this strategy alone will not ensure a permanent solution in all settings. The fairly extensive LF literature is dominated by laboratory research and quantitative field measurement of the impact of LF, particularly local prevalence studies of parasite-infected humans and vectors. As the global elimination programme expands, the absence of sociocultural understanding is being recognized as a critical flaw in ensuring that programmes are appropriate and responsive to local needs and understanding. This paper assesses the current state of sociocultural understanding pertaining to LF. It concludes that, at present, there is insufficient understanding of the sociocultural factors associated with the presence and treatment of the disease, and that appropriate social science methods should be used to address this deficiency and ensure community partnership in delivering and sustaining the success of LF elimination programmes.


Url:
DOI: 10.2471/BLT.06.031047
PubMed: 17639248
PubMed Central: 2636343


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:2636343

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature</title>
<author>
<name sortKey="Wynd, Shona" sort="Wynd, Shona" uniqKey="Wynd S" first="Shona" last="Wynd">Shona Wynd</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Department for International Development, East Kilbride, United Kingdom.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country>
<wicri:regionArea>Department for International Development, East Kilbride</wicri:regionArea>
<wicri:noRegion>East Kilbride</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Australie</country>
<wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Melrose, Wayne D" sort="Melrose, Wayne D" uniqKey="Melrose W" first="Wayne D" last="Melrose">Wayne D. Melrose</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Australie</country>
<wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Durrheim, David N" sort="Durrheim, David N" uniqKey="Durrheim D" first="David N" last="Durrheim">David N. Durrheim</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Australie</country>
<wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">Population Health, Hunter New England Health, Wallsend, 2287, New South Wales, Australia.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Australie</country>
<wicri:regionArea>Population Health, Hunter New England Health, Wallsend, 2287, New South Wales</wicri:regionArea>
<wicri:noRegion>New South Wales</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Carron, Jaime" sort="Carron, Jaime" uniqKey="Carron J" first="Jaime" last="Carron">Jaime Carron</name>
<affiliation wicri:level="1">
<nlm:aff id="aff4">60 Holgate St., Barrie, Ontario, Canada.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Canada</country>
<wicri:regionArea>60 Holgate St., Barrie, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gyapong, Margaret" sort="Gyapong, Margaret" uniqKey="Gyapong M" first="Margaret" last="Gyapong">Margaret Gyapong</name>
<affiliation wicri:level="1">
<nlm:aff id="aff5">Dodowa Health Research Centre, Dodowa, Ghana.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Ghana</country>
<wicri:regionArea>Dodowa Health Research Centre, Dodowa</wicri:regionArea>
<wicri:noRegion>Dodowa</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">17639248</idno>
<idno type="pmc">2636343</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636343</idno>
<idno type="RBID">PMC:2636343</idno>
<idno type="doi">10.2471/BLT.06.031047</idno>
<date when="2007">2007</date>
<idno type="wicri:Area/Pmc/Corpus">004716</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004716</idno>
<idno type="wicri:Area/Pmc/Curation">004715</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">004715</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003A53</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003A53</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature</title>
<author>
<name sortKey="Wynd, Shona" sort="Wynd, Shona" uniqKey="Wynd S" first="Shona" last="Wynd">Shona Wynd</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Department for International Development, East Kilbride, United Kingdom.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country>
<wicri:regionArea>Department for International Development, East Kilbride</wicri:regionArea>
<wicri:noRegion>East Kilbride</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Australie</country>
<wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Melrose, Wayne D" sort="Melrose, Wayne D" uniqKey="Melrose W" first="Wayne D" last="Melrose">Wayne D. Melrose</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Australie</country>
<wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Durrheim, David N" sort="Durrheim, David N" uniqKey="Durrheim D" first="David N" last="Durrheim">David N. Durrheim</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Australie</country>
<wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">Population Health, Hunter New England Health, Wallsend, 2287, New South Wales, Australia.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Australie</country>
<wicri:regionArea>Population Health, Hunter New England Health, Wallsend, 2287, New South Wales</wicri:regionArea>
<wicri:noRegion>New South Wales</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Carron, Jaime" sort="Carron, Jaime" uniqKey="Carron J" first="Jaime" last="Carron">Jaime Carron</name>
<affiliation wicri:level="1">
<nlm:aff id="aff4">60 Holgate St., Barrie, Ontario, Canada.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Canada</country>
<wicri:regionArea>60 Holgate St., Barrie, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gyapong, Margaret" sort="Gyapong, Margaret" uniqKey="Gyapong M" first="Margaret" last="Gyapong">Margaret Gyapong</name>
<affiliation wicri:level="1">
<nlm:aff id="aff5">Dodowa Health Research Centre, Dodowa, Ghana.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Ghana</country>
<wicri:regionArea>Dodowa Health Research Centre, Dodowa</wicri:regionArea>
<wicri:noRegion>Dodowa</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Bulletin of the World Health Organization</title>
<idno type="ISSN">0042-9686</idno>
<imprint>
<date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<title>Abstract</title>
<p>Lymphatic filariasis (LF) is endemic in approximately 80 tropical and subtropical countries. About 120 million people are infected with the parasite and a billion are estimated to be at risk of infection. The main focus of the LF elimination programme to date has been to interrupt transmission by means of annual community-wide treatment campaigns with diethylcarbamazine and albendazole, or albendazole and ivermectin, for a period of four to six years. Although substantial progress has been recorded wherever the strategy has been successfully implemented, initial gains have been accompanied by a realization that this strategy alone will not ensure a permanent solution in all settings. The fairly extensive LF literature is dominated by laboratory research and quantitative field measurement of the impact of LF, particularly local prevalence studies of parasite-infected humans and vectors. As the global elimination programme expands, the absence of sociocultural understanding is being recognized as a critical flaw in ensuring that programmes are appropriate and responsive to local needs and understanding. This paper assesses the current state of sociocultural understanding pertaining to LF. It concludes that, at present, there is insufficient understanding of the sociocultural factors associated with the presence and treatment of the disease, and that appropriate social science methods should be used to address this deficiency and ensure community partnership in delivering and sustaining the success of LF elimination programmes.</p>
</div>
</front>
</TEI>
<pmc article-type="review-article" xml:lang="EN">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id>
<journal-id journal-id-type="publisher-id">BLT</journal-id>
<journal-title>Bulletin of the World Health Organization</journal-title>
<issn pub-type="ppub">0042-9686</issn>
<publisher>
<publisher-name>World Health Organization</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">17639248</article-id>
<article-id pub-id-type="pmc">2636343</article-id>
<article-id pub-id-type="doi">10.2471/BLT.06.031047</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature</article-title>
<trans-title xml:lang="FR">Comprendre l’impact de la filariose lymphatique au niveau communautaire par une analyse de la littérature dans le domaine socioculturel</trans-title>
<trans-title xml:lang="ES">Comprender el impacto comunitario de la filariasis linfática: revisión de la bibliografía sociocultural</trans-title>
<trans-title xml:lang="AR">فەم تأثيـر داء الفيلاريات اللمفي على المجتمع: مراجعة للأدبيات الاجتماعية والثقافية</trans-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wynd</surname>
<given-names>Shona</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Melrose</surname>
<given-names>Wayne D</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Durrheim</surname>
<given-names>David N</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carron</surname>
<given-names>Jaime</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gyapong</surname>
<given-names>Margaret</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<aff id="aff1">
<label>a</label>
Department for International Development, East Kilbride, United Kingdom.</aff>
<aff id="aff2">
<label>b</label>
World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</aff>
<aff id="aff3">
<label>c</label>
Population Health, Hunter New England Health, Wallsend, 2287, New South Wales, Australia.</aff>
<aff id="aff4">
<label>d</label>
60 Holgate St., Barrie, Ontario, Canada.</aff>
<aff id="aff5">
<label>e</label>
Dodowa Health Research Centre, Dodowa, Ghana.</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Correspondence to David Durrheim (e-mail:
<email xlink:href="David.Durrheim@hnehealth.nsw.gov.au">David.Durrheim@hnehealth.nsw.gov.au</email>
).</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2007</year>
</pub-date>
<volume>85</volume>
<issue>6</issue>
<fpage>493</fpage>
<lpage>498</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>2</month>
<year>2006</year>
</date>
<date date-type="rev-recd">
<day>17</day>
<month>11</month>
<year>2006</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>12</month>
<year>2006</year>
</date>
</history>
<permissions>
<copyright-statement>© World Health Organization (WHO) 2007. All rights reserved.</copyright-statement>
<copyright-year>2007</copyright-year>
</permissions>
<abstract xml:lang="EN">
<title>Abstract</title>
<p>Lymphatic filariasis (LF) is endemic in approximately 80 tropical and subtropical countries. About 120 million people are infected with the parasite and a billion are estimated to be at risk of infection. The main focus of the LF elimination programme to date has been to interrupt transmission by means of annual community-wide treatment campaigns with diethylcarbamazine and albendazole, or albendazole and ivermectin, for a period of four to six years. Although substantial progress has been recorded wherever the strategy has been successfully implemented, initial gains have been accompanied by a realization that this strategy alone will not ensure a permanent solution in all settings. The fairly extensive LF literature is dominated by laboratory research and quantitative field measurement of the impact of LF, particularly local prevalence studies of parasite-infected humans and vectors. As the global elimination programme expands, the absence of sociocultural understanding is being recognized as a critical flaw in ensuring that programmes are appropriate and responsive to local needs and understanding. This paper assesses the current state of sociocultural understanding pertaining to LF. It concludes that, at present, there is insufficient understanding of the sociocultural factors associated with the presence and treatment of the disease, and that appropriate social science methods should be used to address this deficiency and ensure community partnership in delivering and sustaining the success of LF elimination programmes.</p>
</abstract>
<trans-abstract xml:lang="FR">
<title>Résumé</title>
<p>La filariose lymphatique (FL) est endémique dans environ 80 pays tropicaux et subtropicaux. Quelque 120 millions de personnes sont infestées par le parasite responsable de cette maladie et on estime à près d’un milliard le nombre de celles exposées au risque d’infestation. A ce jour, l’axe d’intervention principal du programme d’élimination de la FL consistait à interrompre la transmission de la maladie par des séries sur quatre à six ans de campagnes annuelles de traitement des communautés par l’association diéthylcarbamazine/albendazole ou l’association albendazole/ivermectine. Tout en enregistrant des succès substantiels partout où ils avaient réussi à appliquer cette stratégie, les responsables du programme ont néanmoins compris que celle-ci n’apporterait pas seule une solution durable dans tous les contextes. La littérature relativement abondante sur la FL comprend principalement des travaux de recherche sur cette maladie et des évaluations quantitatives sur le terrain de son impact (notamment des études sur la prévalence locale des infestations humaine et vectorielle). A mesure que le programme d’élimination mondiale de la filariose lymphatique se développe, les responsables reconnaissent de plus en plus l’absence de compréhension des aspects socioculturels de la maladie comme une lacune rédhibitoire pour la mise au point de programmes adaptés et répondant aux perceptions et aux besoins locaux. Le présent article évalue l’état actuel des connaissances sur les éléments socioculturels associés à la LF. Sa conclusion est que la compréhension actuelle des facteurs socioculturels liés à la présence et au traitement de cette maladie est insuffisante et qu’il faut recourir à des méthodes appropriées, du domaine des sciences sociales, pour combler cette lacune et pour s’assurer de la participation des communautés à la délivrance des programmes d’élimination de la LF et au maintien de leur succès.</p>
</trans-abstract>
<trans-abstract xml:lang="ES">
<title>Resumen</title>
<p>La filariasis linfática es endémica en aproximadamente 80 países tropicales y subtropicales. Alrededor de 120 millones de personas están infectadas por el parásito que la causa, y se estima que unos mil millones están expuestas al riesgo de infección. El principal objetivo del programa de eliminación de la filariasis linfática hasta la fecha ha sido la interrupción de la transmisión mediante campañas de tratamiento anuales a escala comunitaria con dietilcarbamazina y albendazol, o bien albendazol e ivermectina, durante un periodo de cuatro a seis años. Aunque se han registrado grandes progresos en todos los lugares donde se ha conseguido aplicar eficazmente esa estrategia, paralelamente a las mejoras iniciales ha habido que reconocer que por sí sola la estrategia no garantizará la continuidad de los resultados en todos los entornos. La bibliografía sobre la filariasis linfática, bastante extensa, está dominada por las investigaciones de laboratorio y la medición cuantitativa sobre el terreno del impacto de la enfermedad, en particular por estudios sobre la prevalencia local en poblaciones humanas y de vectores infectadas por el parásito. Conforme se amplía el programa mundial de eliminación, la ausencia de datos sobre el contexto sociocultural se está revelando como un obstáculo fundamental para articular unos programas apropiados y con capacidad de respuesta a las necesidades y las ideas locales. En este artículo se evalúa el estado actual de los conocimientos sobre el entorno sociocultural de la filariasis linfática. Se llega a la conclusión de que por el momento no se conocen suficientemente los factores socioculturales asociados a la presencia y el tratamiento de la enfermedad, y de que deberían utilizarse los métodos sociológicos oportunos para corregir esa deficiencia y asegurar la colaboración de la comunidad en la ejecución de los programas de eliminación de la filariasis linfática y el mantenimiento del éxito con ellos logrado.</p>
</trans-abstract>
<trans-abstract xml:lang="AR">
<title>ملخص</title>
<p>يتوطن داء الفيلاريات اللمفي في ما يقرب من ثمانين بلداً من البلدان المدارية ودون المدارية، ويقدر عدد المصابين بە بمئة وعشرين مليوناً، فيما يزيد عدد المعرضين لخطر العدوى بە عن البليون. وقد تركزت بؤرة الاەتمام الرئيسي لبرنامج التخلُّص من داء الفيلاريات اللمفي على قطع السراية بتنفيذ الحَمَلات السنوية للمعالجة الشاملة للمجتمع بالديمثيل كاربامازين والألبندازول، أو الإيفيرميكتين والألبندازول، لمدة تتـراوح بين أربع وست سنوات. ورغم أن تقدماً ملحوظاً قد تحقق في المناطق التي طُبـِّقَتْ فيەا ەذە الاستـراتيجية بنجاح، فإن المكاسب الأولية أثبتـت أن ەذە الاستـراتيجية لن تكون لوحدەا الحل الدائم في جميع المواقع. ويغلب على الأدبيات المنشورة حول داء الفيلاريات اللمفي البحوث المختبرية والقياسات الميدانية الكمية لتأثير داء الفيلاريات اللمفي، ولاسيما دراسات الانتشار المحلي للمصابين بالعدوى من البشر ومن العوامل الناقلة للمرض. ومع التوسع في البرنامج العالمي لاستئصال المرض، أصبح غياب الفەم الاجتماعي والثقافي ەو العَيْب الرئيسي الذي يحول دون ضمان ملاءمة البرامج لتلبية الاحتياجات والاستجابة لەا وفەمەا. وتقدم ەذە الورقة تقييماً للوضع الحالي للفەم الاجتماعي والثقافي لداء الفيلاريات اللمفي، ثم تَخْلُص إلى أنە يوجد في الوقت الحاضر فەم قاصر للأوضاع الاجتماعية والثقافية المصاحبة لوجود المرض ولمعالجتە، كما يوجد طرق ملائمة في العلوم الاجتماعية ينبغي استخدامەا للتصدي لحالات القصور ەذە، ولضمان الشراكة المجتمعية في تنفيذ وضمان استمرار النجاح لبرامج التخلص من داء الفيلاريات اللمفي.</p>
</trans-abstract>
</article-meta>
</front>
</pmc>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>Canada</li>
<li>Ghana</li>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Wynd, Shona" sort="Wynd, Shona" uniqKey="Wynd S" first="Shona" last="Wynd">Shona Wynd</name>
</noRegion>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Wynd, Shona" sort="Wynd, Shona" uniqKey="Wynd S" first="Shona" last="Wynd">Shona Wynd</name>
</noRegion>
<name sortKey="Durrheim, David N" sort="Durrheim, David N" uniqKey="Durrheim D" first="David N" last="Durrheim">David N. Durrheim</name>
<name sortKey="Durrheim, David N" sort="Durrheim, David N" uniqKey="Durrheim D" first="David N" last="Durrheim">David N. Durrheim</name>
<name sortKey="Melrose, Wayne D" sort="Melrose, Wayne D" uniqKey="Melrose W" first="Wayne D" last="Melrose">Wayne D. Melrose</name>
</country>
<country name="Canada">
<noRegion>
<name sortKey="Carron, Jaime" sort="Carron, Jaime" uniqKey="Carron J" first="Jaime" last="Carron">Jaime Carron</name>
</noRegion>
</country>
<country name="Ghana">
<noRegion>
<name sortKey="Gyapong, Margaret" sort="Gyapong, Margaret" uniqKey="Gyapong M" first="Margaret" last="Gyapong">Margaret Gyapong</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A53 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 003A53 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    RBID
   |clé=     PMC:2636343
   |texte=   Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i   -Sk "pubmed:17639248" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024